Skip to main navigation
CervoMed
  • Investors Overview
  • News & Events
    News Releases Events and Presentations
  • Corporate Governance
    Governance Overview Management Team Board of Directors Committee Composition
  • Financial Information
  • Stock Information
    Stock Quote & Chart Analyst Coverage
  • Shareholder Services
    Investor FAQs Email Alerts IR Contacts

Events and Presentations

Presentations

CervoMed Corporate Presentation
June 15, 2026
2026 American Academy of Neurology Presentation (Abstract #4689)
April 22, 2026
CervoMed Fireside Chat 38thAnnual Roth Conference
March 23, 2026
AD/PD 2026 Oral Presentation: RewinD-LB Clinical Study Results
March 19, 2026
CTAD 2025 Presentation (LB31 – J.P. Taylor et al.)
December 4, 2025
Pagination
  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page ›
  • Last page »

Past Events

H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
Jun 15, 2026 7:00 AM EDT
Webcast
38th Annual ROTH Conference
Mar 23, 2026 3:00 PM EDT
Webcast
CTAD 2025
Dec 4, 2025
CTAD 2025 Video
The Emerging Growth Conference
Oct 22, 2025 11:25 AM EDT
Webcast/ Playback
The Emerging Growth Conference Presentation 1.5 MB
4th Annual ROTH Healthcare Opportunities Conference
Oct 9, 2025 8:00 AM EDT
Webcast/ Playback
H.C. Wainwright 27th Annual Global Investment Conference
Sep 10, 2025 2:00 PM EDT
Webcast
Morgan Stanley’s 23rd Annual Global Healthcare Conference
Sep 8 - Sep 10, 2025
Canaccord Genuity 45th Annual Growth Conference
Aug 12, 2025 2:00 PM EDT
Webcast
CervoMed Results from Week 32 of the Phase 2b RewinD-LB Study
Jul 28, 2025 8:00 AM EDT
Webcast
RewinD-LB Week 32 Extension Results Presentation 1.3 MB
H.C. Wainwright BioConnect Investor Conference
May 20, 2025
Webcast
Pagination
  • Current page 1
  • Page 2
  • Page 3
  • Next page ›
  • Last page »

Contact Investor Relations

Argot Partners
cervomed@argotpartners.com
212-600-1902
Investors@cervomed.com
 

  • Terms of Use
  • Privacy
  • © CervoMed 2026